These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4155279)

  • 21. Beta-adrenolytic, antiarrhythmic and local anaesthetic effects of phenylephrine.
    Reinhardt D; Wagner J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(3):245-61. PubMed ID: 4154414
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 23. Factors determining activity and selectivity of antifibrillatory agents on different types of fibrillation.
    Loebis LH
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):61-75. PubMed ID: 4148409
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].
    Takenaka F; Takeya N
    Nihon Rinsho; 1969 Oct; 27(10):2470-8. PubMed ID: 4390982
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacology of dl-5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (CS-359), a new beta-adrenergic blocking agent.
    Oshima T; Kumakura S; Koike H; Nakayama K
    Jpn J Pharmacol; 1973 Aug; 23(4):497-513. PubMed ID: 4148384
    [No Abstract]   [Full Text] [Related]  

  • 27. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH; Jindal MN; Patel VK; Kelkar VV
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract]   [Full Text] [Related]  

  • 28. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
    Singh BN; Williams EM
    Br J Pharmacol; 1971 Sep; 43(1):10-22. PubMed ID: 4400181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects on cardiac muscle and nerve of a fluorinated decahydroquinoline derivative, L7810, rapidly absorbed after oral administration.
    Bagwell EE; Polster P; Williams EM
    Br J Pharmacol; 1973 Jun; 48(2):183-93. PubMed ID: 4147426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenergic blockade and antiarrhythmic activity of (-)- and (+)-propranolol.
    Flórez J; Pomar JL; Malpartida F
    Rev Esp Fisiol; 1969 Dec; 25(4):287-92. PubMed ID: 4401670
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of hypothermia and pronethalol on ionic correlates of ouabain arrhythmias in dogs.
    el-Fiky SB; Katzung BG
    Circ Res; 1969 Jan; 24(1):43-50. PubMed ID: 4387675
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of B.W. 62-235 and lidocaine with respect to cardiovascular, anti-arrhythmic and local anesthetic actions.
    Paradise RR; Stoelting VK
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):17-29. PubMed ID: 4380176
    [No Abstract]   [Full Text] [Related]  

  • 39. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. 2. Aromatic-substituted analogs of bunolol.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1973 Mar; 16(3):254-7. PubMed ID: 4147388
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.